Total Clarity Wealth Management, Inc. Kazia Therapeutics LTD Transaction History

Total Clarity Wealth Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$7.35 - $12.0 $34,949 - $57,060	-4,755 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$8.65 - $11.64 $41,130 - $55,348	4,755 New	4,755 $54,000
Q2 2021 Jul 26, 2021	SELL	$9.1 - $14.71 $16,289 - $26,330	-1,790 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$8.98 - $12.86 $16,074 - $23,019	1,790 New	1,790 $22,000

2.13M

93.2K

Ticker KZIA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,111,300
Market Cap $87.5M
Description
Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various...

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.